OpenLearning Limited (ASX: OLL) Announces Voluntary Suspension
OpenLearning Limited (ASX: OLL) has announced a voluntary suspension of its securities pending a key announcement regarding a related party loan facility.
OpenLearning Limited (ASX: OLL) has announced a voluntary suspension of its securities pending a key announcement regarding a related party loan facility.
Immutep Limited (ASX: IMM) has announced the initiation of TACTI-004, a Phase III trial for first-line metastatic non-small cell lung cancer.
Integral Diagnostics receives ACCC clearance for its merger with Capitol Health, expecting implementation by 20 December 2024.
Doctor Care Anywhere announces Laura O’Riordan as new CEO from January 2025, focusing on growth and quality in virtual healthcare.
Integral Diagnostics secures ACCC approval for Capitol Health acquisition, requiring divestiture of a clinic in the Melton region.
Anteris Technologies Ltd (ASX: AVR) launches a U.S. IPO for 14.8 million shares to advance its innovative medical solutions.
LTR Pharma Limited secures A$25 million to advance its SPONTAN® treatment through regulatory processes in the U.S. market.
Visioneering Technologies, Inc. (ASX:VTI) has announced its intent to voluntarily delist from the ASX, seeking shareholder approval for the move.
Strata Minerals Limited (ASX:SMX) announces major advancements in gold, uranium, and rare earths exploration projects.
BTC Health announces an exclusive partnership with Corcym, set to enhance annual revenue by $3.6 million and improve profitability.